Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Technology Stocks : Conductus (NASDAQ: CDTS) superconductors -- Ignore unavailable to you. Want to Upgrade?

To: John Finley who wrote (290)	3/22/2000 8:36:00 AM
From: Roger Schelling	Read Replies (1) \| Respond to of 352

John: CDTS sure is volatile, hopefully $30 is the bottom of the range for a while. OT PCHM..I will take this to PM after this. The valuations look compelling. The projected earnings growth looks a little anemic Palo Alto DD seems to see nice growth. The projected earnings growth is striking. Moreover, even if PharmChem?s new products do not succeed, its $44 million base of testing services should be worth considerably more than the current stock price in the event of a merger. pa-investors.com Have a good day, Roger